This document provides sales growth data for the top 103 molecules from January to March 2013 compared to the same period in the previous year. The top performing molecule was Sildenafil, which saw 999% growth. Overall, total selected molecule sales grew 2.21% in the period. Many common molecules saw moderate single-digit percentage growth rates, with a few experiencing declines in sales.